Implantable cardioverter-defibrillators (ICDs) can reduce sudden cardiac death in patients with ischemic heart disease and left ventricular dysfunction, but cumulative costs could preclude their ...

There is a need for an effective strategy to identify patients with ischemic cardiomyopathy who will derive the most and the least benefit from implantable cardioverter-defibrillator (ICD) therapy.

Classic changes of ischemia may be described or explained as follows: 1. ST-segment elevations or depressions that are usually localized (but may be diffuse) and may be associated with such T-wave ...